InMode (INMD) Short-term Investments (2018 - 2026)
InMode (INMD) posted quarterly Short-term Investments of $85.8 million for Q1 2026, down 39.78% year-on-year from $142.5 million in Q1 2025, and down 49.26% on a QoQ basis from $169.2 million in Q4 2025.
InMode (INMD) Short-term Investments (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Short-term Investments for 9 consecutive years, with $85.8 million the latest figure, recorded in Q1 2026.
- Quarterly Short-term Investments fell 39.78% year-over-year to $85.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.8 million (down 39.78% YoY) and the FY2025 annual result came in at $169.2 million, down 2.48% from the prior year.
- Short-term Investments fell to $85.8 million in Q1 2026 per INMD's latest filing, from $169.2 million in the prior quarter.
- Over the last five years, Short-term Investments for INMD reached as high as $303.7 million in Q2 2024 and fell as low as $55.9 million in Q2 2022.
- A 5-year average of $142.8 million and a median of $142.5 million in 2025 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2024 — Short-term Investments surged 339.54% — and 2025, when it sank 63.43%.
- Year by year, Short-term Investments stood at $75.3 million in 2022, then jumped by 197.06% to $223.5 million in 2023, then declined by 22.41% to $173.5 million in 2024, then declined by 2.48% to $169.2 million in 2025, then plunged by 49.26% to $85.8 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $85.8 million, $169.2 million, and $158.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.83 Mn |
| Dec 31, 2025 | 169.16 Mn |
| Sep 30, 2025 | 158.35 Mn |
| Jun 30, 2025 | 111.06 Mn |
| Mar 31, 2025 | 142.52 Mn |
| Dec 31, 2024 | 173.46 Mn |
| Sep 30, 2024 | 238.59 Mn |
| Jun 30, 2024 | 303.69 Mn |
| Mar 31, 2024 | 258.83 Mn |
| Dec 31, 2023 | 223.55 Mn |
| Sep 30, 2023 | 156.25 Mn |
| Jun 30, 2023 | 69.09 Mn |
| Mar 31, 2023 | 75.82 Mn |
| Dec 31, 2022 | 75.25 Mn |
| Sep 30, 2022 | 74.41 Mn |
| Jun 30, 2022 | 55.91 Mn |
| Mar 31, 2022 | 56.39 Mn |
| Dec 31, 2021 | 53.25 Mn |
| Sep 30, 2021 | 53.22 Mn |
| Jun 30, 2021 | 52.26 Mn |